ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

(a) The annual meeting of stockholders of Eloxx Pharmaceuticals, Inc. (the "Company") was held on May 20, 2020.

(b) Stockholders voted on the matters set forth below:

Proposal 1. Election of Directors:





                                            For       Withheld    Broker Non-Votes
    Zafrira Avnur, Ph.D.                 20,901,103      86,487          6,223,430
    Tomer Kariv                          20,890,688      96,902          6,223,430
    Martijn Kleijwegt                    20,923,026      64,564          6,223,430
    Silvia Noiman, Ph.D., M.B.A.         20,917,597      69,993          6,223,430
    Ran Nussbaum                         20,877,141     110,449          6,223,430
    Steven Rubin                         18,138,879   2,848,711          6,223,430
    Jasbir Seehra, Ph.D.                 20,900,883      86,707          6,223,430
    Gadi Veinrib                         20,900,573      87,017          6,223,430
    Gregory C. Williams, Ph.D., M.B.A.   20,918,642      68,948          6,223,430




Proposal 2. Ratification of Appointment Deloitte & Touche LLP as the Company's
Independent Registered Public Accounting Firm for the Fiscal Year Ending
December 31, 2020:



                           For              27,164,875
                           Against              23,624
                           Abstain              22,521
                           Broker Non-Votes          0

Proposal 3. Advisory Vote on Executive Compensation:





                           For              20,867,124
                           Against             113,878
                           Abstain               6,588
                           Broker Non-Votes  6,223,430




(c) Not applicable.



(d) Not applicable.

© Edgar Online, source Glimpses